Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306407341> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- W4306407341 endingPage "1078" @default.
- W4306407341 startingPage "1071" @default.
- W4306407341 abstract "Chris Brown is the Director of GMP Manufacturing within the Therapeutic Cell Production Core, Seattle Children’s Therapeutics’ GMP cell manufacturing facility. He leads the facility’s manufacturing/process development team and played a key role in initial design, stand-up, and ongoing development of the TCPC facilities, team, and manufacturing methodologies. He has more than 20 years’ experience in the manufacturing of cellular products for Phase 1 and 2 clinical trials, with a focus in translating cutting-edge research into first-in-human cellular therapeutics. He joined Seattle Children’s Research Institute from the Fred Hutchinson Cancer Research Center in 2010, where he led the manufacturing team within the Cellular Production Facility cleanroom. He holds a BA in Biology from Carleton College in Northfield, Minnesota.Sean Werner is the Chief Technology Officer – Cell Processing at BioLife Solutions, a leading provider of bioproduction tools and services to the cell and gene therapy and broader biopharma markets. BioLife acquired Sexton Biotechnologies in 2021 where Sean was President of the company known for providing processing and handling solutions for the CGT industry. Sean received his PhD from Purdue University in Biology followed by post-doctoral positions at the Indiana University School of Medicine and Eli Lilly. Sean has previous experience filling various roles in the global regulatory and general management functions supporting medical devices, autologous cell therapy, and single use disposable development programs. In his 15 years working in the life science industry, he has guided pre-clinical and clinical testing and submission strategies leading to global commercialization of multiple medical devices and bioprocessing tools." @default.
- W4306407341 created "2022-10-17" @default.
- W4306407341 creator A5007325940 @default.
- W4306407341 creator A5014431408 @default.
- W4306407341 date "2022-09-03" @default.
- W4306407341 modified "2023-10-18" @default.
- W4306407341 title "Learning from pediatric CAR-T development: insights from manufacturing unique patient doses" @default.
- W4306407341 doi "https://doi.org/10.18609/cgti.2022.158" @default.
- W4306407341 hasPublicationYear "2022" @default.
- W4306407341 type Work @default.
- W4306407341 citedByCount "0" @default.
- W4306407341 crossrefType "journal-article" @default.
- W4306407341 hasAuthorship W4306407341A5007325940 @default.
- W4306407341 hasAuthorship W4306407341A5014431408 @default.
- W4306407341 hasBestOaLocation W43064073411 @default.
- W4306407341 hasConcept C15744967 @default.
- W4306407341 hasConcept C71924100 @default.
- W4306407341 hasConceptScore W4306407341C15744967 @default.
- W4306407341 hasConceptScore W4306407341C71924100 @default.
- W4306407341 hasIssue "08" @default.
- W4306407341 hasLocation W43064073411 @default.
- W4306407341 hasOpenAccess W4306407341 @default.
- W4306407341 hasPrimaryLocation W43064073411 @default.
- W4306407341 hasRelatedWork W1506200166 @default.
- W4306407341 hasRelatedWork W1995515455 @default.
- W4306407341 hasRelatedWork W2048182022 @default.
- W4306407341 hasRelatedWork W2080531066 @default.
- W4306407341 hasRelatedWork W2604872355 @default.
- W4306407341 hasRelatedWork W2748952813 @default.
- W4306407341 hasRelatedWork W2899084033 @default.
- W4306407341 hasRelatedWork W3031052312 @default.
- W4306407341 hasRelatedWork W3032375762 @default.
- W4306407341 hasRelatedWork W3108674512 @default.
- W4306407341 hasVolume "08" @default.
- W4306407341 isParatext "false" @default.
- W4306407341 isRetracted "false" @default.
- W4306407341 workType "article" @default.